Heart Test Laboratories (HSCS) Competitors $3.83 +0.41 (+11.99%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends HSCS vs. SSKN, MHUA, LYRA, PYPD, QTI, PXDT, PETV, ICU, STRR, and PAVMShould you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include STRATA Skin Sciences (SSKN), Meihua International Medical Technologies (MHUA), Lyra Therapeutics (LYRA), PolyPid (PYPD), QT Imaging (QTI), Pixie Dust Technologies (PXDT), PetVivo (PETV), SeaStar Medical (ICU), Star Equity (STRR), and PAVmed (PAVM). These companies are all part of the "medical equipment" industry. Heart Test Laboratories vs. STRATA Skin Sciences Meihua International Medical Technologies Lyra Therapeutics PolyPid QT Imaging Pixie Dust Technologies PetVivo SeaStar Medical Star Equity PAVmed Heart Test Laboratories (NASDAQ:HSCS) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk. Does the media favor HSCS or SSKN? In the previous week, Heart Test Laboratories had 4 more articles in the media than STRATA Skin Sciences. MarketBeat recorded 4 mentions for Heart Test Laboratories and 0 mentions for STRATA Skin Sciences. Heart Test Laboratories' average media sentiment score of 0.88 beat STRATA Skin Sciences' score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the media. Company Overall Sentiment Heart Test Laboratories Positive STRATA Skin Sciences Neutral Is HSCS or SSKN more profitable? Heart Test Laboratories has a net margin of 0.00% compared to STRATA Skin Sciences' net margin of -28.72%. STRATA Skin Sciences' return on equity of -69.33% beat Heart Test Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Heart Test LaboratoriesN/A -144.12% -94.48% STRATA Skin Sciences -28.72%-69.33%-17.55% Does the MarketBeat Community prefer HSCS or SSKN? STRATA Skin Sciences received 218 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 83.33% of users gave Heart Test Laboratories an outperform vote while only 63.90% of users gave STRATA Skin Sciences an outperform vote. CompanyUnderperformOutperformHeart Test LaboratoriesOutperform Votes583.33% Underperform Votes116.67%STRATA Skin SciencesOutperform Votes22363.90% Underperform Votes12636.10% Which has stronger valuation & earnings, HSCS or SSKN? Heart Test Laboratories has higher earnings, but lower revenue than STRATA Skin Sciences. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Heart Test Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeart Test Laboratories$14.70K237.88-$6.61M-$7.91-0.48STRATA Skin Sciences$32.68M0.37-$10.83M-$2.66-1.09 Do analysts recommend HSCS or SSKN? Heart Test Laboratories presently has a consensus price target of $13.50, suggesting a potential upside of 252.48%. Given Heart Test Laboratories' stronger consensus rating and higher possible upside, analysts clearly believe Heart Test Laboratories is more favorable than STRATA Skin Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00STRATA Skin Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders believe in HSCS or SSKN? 17.2% of Heart Test Laboratories shares are owned by institutional investors. Comparatively, 32.4% of STRATA Skin Sciences shares are owned by institutional investors. 1.8% of Heart Test Laboratories shares are owned by insiders. Comparatively, 39.0% of STRATA Skin Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility & risk, HSCS or SSKN? Heart Test Laboratories has a beta of 3.23, suggesting that its stock price is 223% more volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. SummaryHeart Test Laboratories beats STRATA Skin Sciences on 11 of the 18 factors compared between the two stocks. Ad Stansberry Research2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisisDan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. Get Heart Test Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeart Test LaboratoriesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.50M$9.53B$5.14B$9.08BDividend YieldN/A1.38%5.09%4.23%P/E Ratio-0.1819.5690.0517.20Price / Sales237.8832.801,117.09117.04Price / CashN/A22.3743.1037.85Price / Book0.345.494.784.78Net Income-$6.61M$182.72M$120.31M$225.60M7 Day Performance1.64%-4.48%-1.92%-1.23%1 Month Performance43.45%-5.98%13.65%0.46%1 Year Performance-77.86%-13.75%28.34%15.24% Heart Test Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeart Test Laboratories2.2792 of 5 stars$3.83+12.0%$13.50+252.5%-75.7%$3.50M$14,700.00-0.1810Earnings ReportAnalyst ForecastNews CoverageGap UpSSKNSTRATA Skin Sciences1.0262 of 5 stars$2.99-0.3%N/A-51.5%$12.47M$32.68M-1.11120MHUAMeihua International Medical Technologies0.6851 of 5 stars$0.49-1.5%N/A-86.4%$12.38M$94.25M0.00620Gap DownLYRALyra Therapeutics2.4053 of 5 stars$0.19+1.6%$4.50+2,324.6%-96.1%$12.15M$1.47M-0.1250Gap DownPYPDPolyPid2.3344 of 5 stars$2.43-6.9%$12.00+393.8%-17.6%$11.66MN/A-0.3080Analyst RevisionHigh Trading VolumeQTIQT ImagingN/A$0.45-9.3%N/AN/A$9.90M$4.00M0.00N/APXDTPixie Dust Technologies1.8534 of 5 stars$0.58+9.2%$5.21+798.4%N/A$8.62M$993.02M0.0078High Trading VolumePETVPetVivoN/A$0.41-0.9%N/A-61.2%$8.36M$970,000.00-0.8520News CoverageGap UpICUSeaStar Medical0.1058 of 5 stars$1.84-7.5%N/A-81.6%$8.21M$68,000.00-0.172STRRStar Equity1.0247 of 5 stars$2.48-5.7%N/A-57.9%$7.98M$50.38M-1.02171News CoverageGap UpHigh Trading VolumePAVMPAVmed3.7482 of 5 stars$0.72-5.8%$19.00+2,537.4%-84.8%$7.98M$2.45M-0.1890News Coverage Related Companies and Tools Related Companies STRATA Skin Sciences Competitors Meihua International Medical Technologies Competitors Lyra Therapeutics Competitors PolyPid Competitors QT Imaging Competitors Pixie Dust Technologies Competitors PetVivo Competitors SeaStar Medical Competitors Star Equity Competitors PAVmed Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSCS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.